Yahoo · Sep 14, 2026
Olin, Huntsman Merger of Equals Clears U.S. Antitrust Hurdle
Olin's proposed merger clears a key U.S. antitrust hurdle, with over $400M in expected synergies and a first-half 2027 closing target.
NASDAQ · HUN
Basic Materials · Chemicals
$9.22
Down-$0.08 (-0.86%)
Updated Sep 16, 2026, 12:02 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
HUN closed at $9.22 after 20 trading sessions, down 8.26% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $9.15 | $9.33 | $9.085 | $9.22 | 4.17M |
| Sep 14, 2026 | $9.51 | $9.58 | $9.29 | $9.30 | 2.09M |
| Sep 11, 2026 | $9.68 | $9.75 | $9.48 | $9.54 | 1.64M |
| Sep 10, 2026 | $9.51 | $9.735 | $9.465 | $9.53 | 2.23M |
| Sep 9, 2026 | $9.89 | $9.99 | $9.55 | $9.58 | 2.07M |
| Sep 8, 2026 | $9.76 | $9.91 | $9.545 | $9.80 | 2.15M |
| Sep 4, 2026 | $9.385 | $9.71 | $9.282 | $9.62 | 1.64M |
| Sep 3, 2026 | $9.81 | $9.81 | $9.35 | $9.40 | 1.91M |
| Sep 2, 2026 | $9.43 | $9.815 | $9.405 | $9.71 | 1.91M |
| Sep 1, 2026 | $9.46 | $9.57 | $9.34 | $9.39 | 1.67M |
| Aug 31, 2026 | $9.57 | $9.6228 | $9.39 | $9.58 | 3.08M |
| Aug 28, 2026 | $9.82 | $9.89 | $9.45 | $9.47 | 1.62M |
| Aug 27, 2026 | $9.58 | $9.69 | $9.455 | $9.65 | 2.05M |
| Aug 26, 2026 | $9.59 | $9.645 | $9.3809 | $9.63 | 2.7M |
| Aug 25, 2026 | $9.57 | $9.57 | $9.33 | $9.53 | 2.5M |
| Aug 24, 2026 | $9.95 | $9.99 | $9.59 | $9.60 | 3.01M |
| Aug 21, 2026 | $10.23 | $10.31 | $9.95 | $9.97 | 1.47M |
| Aug 20, 2026 | $10.205 | $10.26 | $9.96 | $10.16 | 1.69M |
| Aug 19, 2026 | $10.22 | $10.515 | $10.15 | $10.18 | 1.94M |
| Aug 18, 2026 | $10.33 | $10.43 | $10.02 | $10.05 | 2.2M |
The latest Smart Investors Daily articles mentioning HUN.
HUN research
Company profile and research snapshot.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 15, 2026 | Citigroup | Neutral | — |
| Sep 11, 2026 | Keybanc | Overweight | — |
| Aug 4, 2026 | Wells Fargo | Equal-Weight | — |
| Aug 3, 2026 | RBC Capital | Sector Perform | — |
| Aug 3, 2026 | UBS | Neutral | — |
Generated Sep 16, 2026, 11:11 AM
Huntsman Corporation shares declined 0.86% today despite positive regulatory news regarding its proposed merger with Olin Corporation. The modest selloff suggests the market may be digesting broader chemical sector headwinds or taking profits following the antitrust clearance announcement.
Bottom line: Huntsman's modest decline today masks a meaningful regulatory victory with the antitrust clearance, which substantially de-risks the Olin merger path forward. Investors should monitor remaining approval timelines and market conditions, as deal completion could meaningfully reshape the company's competitive profile and financial performance.
Yahoo · Sep 14, 2026
Olin's proposed merger clears a key U.S. antitrust hurdle, with over $400M in expected synergies and a first-half 2027 closing target.
Yahoo · Sep 11, 2026
Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) today announced that the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") in connection with the pending merger of the two companies has expired. The expiration of the HSR Act waiting period satisfies one of the key closing conditions to the pending merger of equals.
Benzinga · Sep 11, 2026
Keybanc analyst Salvator Tiano initiates coverage on Huntsman (NYSE:HUN) with a Overweight rating and announces Price Target of $14.
Yahoo · Sep 1, 2026
OLN's cost cuts and planned Huntsman merger could boost earnings, while weak demand, leverage and cash flow remain key headwinds.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HUN.